Our reporters bring you news and highlights from BIO’s in-person and virtual events.
Industry, academic, and policy leaders at BIO 2026 discussed how federal research funding, private investment, and public-private partnerships can strengthen the U.S. biopharma ecosystem […]
The new BIO-Norstella State of Emerging Biotech report finds venture capital has returned, pipelines are becoming more efficient, and emerging biotech companies continue to
BIO 2026: As capital returns, focus on quality over quantity Read More »
Executives at BIO 2026 said biotech partnerships, licensing deals, and acquisitions remain strong as companies adapt their business development strategies to navigate policy, regulatory,
BIO 2026: Biotech dealmakers navigate uncertainty, pursue opportunities Read More »
From drug discovery to target identification, biotech leaders explored where AI is delivering results today, why data quality matters, and how companies can successfully
BIO 2026: Where AI is delivering – and where biotech must go next Read More »
BIO’s partnering platform connects biotechnology companies, investors, and strategic partners, making the BIO International Convention one of the industry’s largest business development events. A
BIO 2026: The business of biotech runs on partnerships Read More »
BIO 2026 brings together 20,000 biotechnology leaders in San Diego for four days of partnering, policy discussions, AI, and innovation as the industry celebrates
BIO 2026 begins in San Diego, marking 50 years of biotech innovation Read More »
“AI systems will likely have a central role over the next several years in almost every component of the biotech ecosystem,” says Joe Franklin,
BIO 2026: What to know about the AI Summit Read More »
The last time the BIO International Convention was in San Diego, in 2024, Ram May-Ron of the non-dilutive funding specialists FreeMind Group began discussing
BIO 2026: Partnering meetings fill up for industry’s biggest gathering Read More »
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026 Read More »
“We’re finding that the most disruptive pieces of legislation are much more likely to advance in state legislatures first, before eventually gaining traction at
State of play: BIO Coffee Chat covers how state policies impact access Read More »
